S
Senti Biosciences Inc
NASDAQ:SNTI
Senti Biosciences Inc
NASDAQ:SNTI
Price:
0.7901
USD
-10.36%
Market Closed
Market Cap:
$20.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Senti Biosciences Inc
NASDAQ:SNTI
|
US |
|
A
|
Ascendis Health Ltd
JSE:ASC
|
ZA |
|
B
|
BKS Bank AG
XBER:BK5
|
AT |
|
Genesis Healthcare Inc
OTC:GENN
|
US |
|
Danone SA
OTC:GPDNF
|
FR |
|
K-Tig Ltd
ASX:KTG
|
AU |
|
Nippon Thompson Co Ltd
TSE:6480
|
JP |
Cash Flow Statement
Cash Flow Statement
Senti Biosciences Inc
Senti Biosciences Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(53)
|
(45)
|
(55)
|
(46)
|
(46)
|
(51)
|
(58)
|
(65)
|
(72)
|
(71)
|
(71)
|
(64)
|
(57)
|
(71)
|
(53)
|
(55)
|
(58)
|
(48)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Stock-Based Compensation |
1
|
2
|
2
|
3
|
11
|
13
|
16
|
19
|
14
|
12
|
10
|
7
|
3
|
3
|
2
|
2
|
4
|
5
|
|
| Other Non-Cash Items |
13
|
13
|
19
|
8
|
4
|
6
|
8
|
10
|
14
|
9
|
10
|
6
|
2
|
21
|
4
|
5
|
7
|
(8)
|
|
| Change in Working Capital |
1
|
2
|
1
|
1
|
4
|
6
|
14
|
12
|
7
|
4
|
5
|
6
|
8
|
11
|
4
|
2
|
(1)
|
2
|
|
| Cash from Operating Activities |
(38)
N/A
|
(30)
+22%
|
(35)
-17%
|
(36)
-5%
|
(37)
-1%
|
(38)
-4%
|
(35)
+8%
|
(41)
-18%
|
(49)
-19%
|
(54)
-11%
|
(52)
+4%
|
(48)
+9%
|
(42)
+11%
|
(35)
+18%
|
(41)
-19%
|
(44)
-6%
|
(48)
-11%
|
(50)
-3%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(6)
|
(13)
|
(24)
|
(37)
|
(41)
|
(41)
|
(33)
|
(21)
|
(12)
|
(6)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
(41)
|
(44)
|
(22)
|
1
|
42
|
45
|
23
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
11
N/A
|
(2)
N/A
|
(6)
-133%
|
(13)
-129%
|
(24)
-85%
|
(37)
-56%
|
(82)
-123%
|
(84)
-3%
|
(54)
+35%
|
(19)
+65%
|
30
N/A
|
40
+32%
|
21
-46%
|
0
-99%
|
0
-77%
|
0
+44%
|
(0)
N/A
|
(0)
-44%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
107
|
99
|
69
|
65
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
49
|
51
|
52
|
52
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other |
(1)
|
(0)
|
(0)
|
(0)
|
118
|
117
|
117
|
118
|
(0)
|
(0)
|
0
|
0
|
0
|
2
|
5
|
3
|
2
|
(0)
|
|
| Cash from Financing Activities |
106
N/A
|
98
-7%
|
68
-30%
|
64
-6%
|
119
+84%
|
118
-1%
|
119
+1%
|
119
+0%
|
1
-99%
|
1
+73%
|
1
-29%
|
1
+4%
|
1
-35%
|
3
+462%
|
54
+1 693%
|
53
-1%
|
54
+2%
|
52
-4%
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
79
N/A
|
66
-16%
|
28
-57%
|
15
-46%
|
59
+281%
|
43
-27%
|
2
-96%
|
(6)
N/A
|
(103)
-1 549%
|
(72)
+30%
|
(22)
+70%
|
(7)
+66%
|
(21)
-179%
|
(32)
-54%
|
12
N/A
|
10
-22%
|
6
-41%
|
2
-69%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(40)
N/A
|
(32)
+20%
|
(40)
-26%
|
(49)
-22%
|
(60)
-23%
|
(75)
-24%
|
(76)
-2%
|
(82)
-7%
|
(82)
0%
|
(75)
+9%
|
(64)
+14%
|
(53)
+17%
|
(44)
+17%
|
(35)
+21%
|
(41)
-19%
|
(44)
-6%
|
(49)
-11%
|
(50)
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
